4/A: Clearwater Analytics CEO Amends Stock Ownership Filing

Sentiment:

Insider Transaction Amendment


Clearwater Analytics CEO Sandeep Sahai filed an amended Form 4 to correct a scrivener's error, detailing recent stock option exercises and sales.

Summary

  • Sandeep Sahai, CEO and Director of Clearwater Analytics Holdings, Inc., filed an amended Form 4 (Form 4/A) to correct a scrivener's error in the total number of derivative securities beneficially owned in Table II.
  • On August 20, 2025, Mr. Sahai acquired 7,094 shares of Class A Common Stock by exercising stock options at an exercise price of $4.4 per share.
  • Concurrently, 4,056 shares were disposed of to cover tax withholding obligations in connection with the option exercise and settlement, at a price of $20.01 per share. This disposition was mandated by the Issuer and not a discretionary transaction.
  • An additional 3,038 shares were sold at a weighted average price of $20.01 per share (ranging from $20.00 to $20.015) pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2024.
  • Following these transactions, Mr. Sahai directly beneficially owns 895,663 shares of Class A Common Stock and 94,967 stock options.

Sentiment

Score: 5

Explanation: The filing is neutral, reporting routine insider transactions (option exercise, tax withholding, and planned sales) and an administrative correction. It provides no new information on company performance or strategic direction that would alter sentiment.

Positives

  • The CEO exercised stock options at a significantly lower price ($4.4) compared to the market price at the time of sale ($20.01), indicating a profitable transaction for the insider.
  • The sale of shares was executed under a pre-arranged Rule 10b5-1 trading plan, which suggests a structured approach to managing personal equity holdings rather than an immediate reaction to market conditions.

Negatives

  • The CEO's direct beneficial ownership of Class A Common Stock decreased by 4,056 shares due to tax withholding and by 3,038 shares due to a planned sale, totaling a reduction of 7,094 shares from the acquired amount.

Future Outlook

The filing details the vesting schedule for previously granted stock options, with various tranches vesting between March 2019 and March 2023, and an overall expiration date of November 29, 2028 for the derivative securities.

Industry Context

This Form 4/A filing is a routine disclosure of insider transactions and does not provide information relevant to broader industry trends or competitive landscape. It solely pertains to the personal equity management of a key executive.

Comparison to Industry Standards

  • This filing is a standard regulatory disclosure for insider transactions (Form 4/A) and does not contain information that allows for a comparison of company performance or projects against global benchmarks or specific comparable companies. The transactions themselves are typical for executives managing equity compensation.

Stakeholder Impact

  • Shareholders: The filing indicates a minor, pre-planned reduction in the CEO's direct shareholding, which is a routine event for executives managing equity compensation and is unlikely to have a significant impact on shareholder confidence or company valuation.
  • Employees, Customers, Suppliers, Creditors: This filing has no direct or material impact on these stakeholders as it pertains solely to an executive's personal equity transactions and a minor administrative correction.

Next Steps

  • No specific future actions or milestones for the company are mentioned in this filing. The reporting person's Rule 10b5-1 trading plan, adopted on September 9, 2024, indicates a pre-planned strategy for future equity sales.

Key Dates

DateDescription
03/19/2019Vesting of 370,000 stock option shares.
03/19/2020Vesting of 370,000 stock option shares.
11/02/2020Vesting of 610,500 stock option shares.
03/19/2021Vesting of 166,500 stock option shares.
03/19/2022Vesting of 166,500 stock option shares.
03/19/2023Vesting of 166,500 stock option shares.
09/09/2024Adoption date of Rule 10b5-1 trading plan by the reporting person.
08/20/2025Date of stock option exercise and related share dispositions.
08/25/2025Filing date of the amended Form 4.
11/29/2028Expiration date of stock options.

Recommendation

hold

This filing is a routine insider transaction report (Form 4/A) detailing the exercise of stock options and subsequent sales by the CEO, primarily for tax obligations and a pre-arranged 10b5-1 plan. The amendment corrects a minor error in derivative holdings. It does not provide new information on company performance, strategy, or financial health that would warrant a change in investment recommendation. The sales are part of a pre-planned strategy and tax obligations, not necessarily indicative of a change in management's outlook on the company's future, thus a 'hold' recommendation remains appropriate based solely on this filing.

Keywords

Clearwater Analytics, CWAN, Sandeep Sahai, Form 4/A, Insider Trading, Stock Options, 10b5-1 Plan, CEO, Equity Sales, Beneficial Ownership, Amendment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.